STOCK TITAN
  1. Home
  2. News
  3. MDNA

Medicenna Therapeutics (MDNA) Stock News, Jul-Sep 2023

MDNA Nasdaq
News

Medicenna to Participate at The H.C. Wainwright 25th Annual Global Investment Conference

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
conferences
-
News

Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.87%
Tags
management
-
News

Medicenna Establishes Boston Presence, Appoints Brent Meadows as Chief Business Officer, and Bolsters Management

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
management
News

Medicenna Completes MDNA11 Dose Escalation and Commences Monotherapy Dose Expansion in the Phase 1/2 ABILITY Study

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.26%
Tags
clinical trial
-
News

Medicenna Appoints Dr. Arash Yavari as Chair of Development Advisory Committee 

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.57%
Tags
management
-
News

Medicenna Therapeutics to Provide Clinical Update from Phase 1/2 ABILITY Study on August 9, 2023

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.13%
Tags
clinical trial
News

Medicenna Strengthens IP Portfolio with U.S. Patent Granted for the Use of Interleukin-2 Superkine Fusion Proteins in Oncology

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.11%
Tags
none
-
News

Medicenna Reports First Quarter Fiscal 2024 Financial Results and Operational Highlights

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.27%
Tags
earnings
-
News

Medicenna Presents at National Brain Tumor Society's Research Round Table

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.09%
Tags
none
News

Medicenna Extends Period to Exercise Certain Warrants

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.99%
Tags
offering